Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29031778

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2017 Nov
First author
Tjan-Heijnen VCG

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Nov;18(11):1431-1433. doi: 10.1016/S1470-2045(17)30787-8.
    note
    Source null
    related pmid
    29031779
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2017 Nov;18(11):e642. doi: 10.1016/S1470-2045(17)30803-3.
    note
    Source null
    related pmid
    29208396
    relationship
    Erratum in

Authors and identifiers

  1. name
    Tjan-Heijnen VCG
    type
    Author
  2. name
    van Hellemond IEG
    type
    Author
  3. name
    Peer PGM
    type
    Author
  4. name
    Swinkels ACP
    type
    Author
  5. name
    Smorenburg CH
    type
    Author
  6. name
    van der Sangen MJC
    type
    Author
  7. name
    Kroep JR
    type
    Author
  8. name
    De Graaf H
    type
    Author
  9. name
    Honkoop AH
    type
    Author
  10. name
    Erdkamp FLG
    type
    Author
  11. name
    van den Berkmortel FWPJ
    type
    Author
  12. name
    de Boer M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tjan-Heijnen VCG
    type
    Author
  2. name
    van Hellemond IEG
    type
    Author
  3. name
    Peer PGM
    type
    Author
  4. name
    Swinkels ACP
    type
    Author
  5. name
    Smorenburg CH
    type
    Author
  6. name
    van der Sangen MJC
    type
    Author
  7. name
    Kroep JR
    type
    Author
  8. name
    De Graaf H
    type
    Author
  9. name
    Honkoop AH
    type
    Author
  10. name
    Erdkamp FLG
    type
    Author
  11. name
    van den Berkmortel FWPJ
    type
    Author
  12. name
    de Boer M
    type
    Author
bibliography ids
  1. nci-bib-4014edc650efb117f0f8d96a
book metadata
content sha256
839d35a71235683e91d4e2dde5e1c2b045dca383c7f5e59f5261999c74cab1ba
document type
citation
dois
  1. 10.1016/S1470-2045(17)30600-9
electronic publication date
display
2017 Oct 12
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29031778
immutable id
pubmed:29031778@839d35a71235683e91d4e2dde5e1c2b045dca383c7f5e59f5261999c74cab1ba
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1502-1511
volume
18
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Nov;18(11):1431-1433. doi: 10.1016/S1470-2045(17)30787-8.
    note
    Source null
    related pmid
    29031779
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2017 Nov;18(11):e642. doi: 10.1016/S1470-2045(17)30803-3.
    note
    Source null
    related pmid
    29208396
    relationship
    Erratum in
outcomes validated
false
pmid
29031778
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
f20e5bf7d44c00f848de2cce03b029daeaed15e543aadda663795299794e61a6
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Nov
precision
month
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29031778/
title
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.

Preserved source evidence · Not medical advice